- Home
- PRPH vs IMNN Comparison
PRPH vs IMNN Comparison
Compare PRPH & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPH
- IMNN
- Stock Information
- Founded
- PRPH 1989
- IMNN 1982
- Country
- PRPH United States
- IMNN United States
- Employees
- PRPH N/A
- IMNN N/A
- Industry
- PRPH Biotechnology: Pharmaceutical Preparations
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- PRPH Health Care
- IMNN Health Care
- Exchange
- PRPH Nasdaq
- IMNN Nasdaq
- Market Cap
- PRPH 10.7M
- IMNN 13.6M
- IPO Year
- PRPH 1997
- IMNN 1985
- Fundamental
- Price
- PRPH $0.43
- IMNN $0.88
- Analyst Decision
- PRPH
- IMNN Strong Buy
- Analyst Count
- PRPH 0
- IMNN 2
- Target Price
- PRPH N/A
- IMNN $20.50
- AVG Volume (30 Days)
- PRPH 27.1M
- IMNN 141.9K
- Earning Date
- PRPH 03-18-2025
- IMNN 05-12-2025
- Dividend Yield
- PRPH N/A
- IMNN N/A
- EPS Growth
- PRPH N/A
- IMNN N/A
- EPS
- PRPH N/A
- IMNN N/A
- Revenue
- PRPH $12,753,000.00
- IMNN N/A
- Revenue This Year
- PRPH $36.93
- IMNN N/A
- Revenue Next Year
- PRPH $132.05
- IMNN N/A
- P/E Ratio
- PRPH N/A
- IMNN N/A
- Revenue Growth
- PRPH N/A
- IMNN N/A
- 52 Week Low
- PRPH $0.22
- IMNN $0.64
- 52 Week High
- PRPH $7.48
- IMNN $3.65
- Technical
- Relative Strength Index (RSI)
- PRPH 48.83
- IMNN 49.35
- Support Level
- PRPH $0.31
- IMNN $0.86
- Resistance Level
- PRPH $0.46
- IMNN $0.93
- Average True Range (ATR)
- PRPH 0.07
- IMNN 0.05
- MACD
- PRPH 0.00
- IMNN 0.00
- Stochastic Oscillator
- PRPH 46.28
- IMNN 61.00
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.
About IMNN Imunon Inc.
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.